The Journal of Urology
Volume 180, Issue 2 , Pages 451-460 , August 2008

A Critical Review of Clinical Practice Guidelines for the Management of Clinically Localized Prostate Cancer

  • Philipp Dahm

      Affiliations

    • Department of Urology, University of Florida, College of Medicine, Gainesville, Florida
    • Corresponding Author InformationCorrespondence: Department of Urology, University of Florida, College of Medicine, Health Science Center, Box 100247, Room N2-15, Gainesville, Florida 32610-0247 (telephone: 352-273-7647; FAX: 352-392-8846).
    • Nothing to disclose.
    • ,
  • Lawrence L. Yeung

      Affiliations

    • Department of Urology, University of Florida, College of Medicine, Gainesville, Florida
    • Nothing to disclose.
    • ,
  • Sam S. Chang

      Affiliations

    • Department of Urologic Surgery, Vanderbilt University, Nashville, Tennessee
    • Financial interest and/or other relationship with sanofi aventis and Indevus.
    • ,
  • Michael S. Cookson

      Affiliations

    • Department of Urologic Surgery, Vanderbilt University, Nashville, Tennessee
    • Financial interest and/or other relationship with sanofi aventis, Indevus and GSK.

Received 8 November 2007

References 

  1. Shaneyfelt TM, Mayo-Smith MF, Rothwangl J. Are guidelines following guidelines? (The methodological quality of clinical practice guidelines in the peer-reviewed medical literature). JAMA. 1999;281:1900
  2. Guyatt G, Vist G, Falck-Ytter Y, Kunz R, Magrini N, Schunemann H. An emerging consensus on grading recommendations?. ACP J Club. 2006;144:A8
  3. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490
  4. Oxman AD, Fretheim A, Schunemann HJ. Improving the use of research evidence in guideline development: introduction. Health Res Policy Syst. 2006;4:12
  5. Schunemann HJ, Fretheim A, Oxman ADand WHO Advisory Committee on Health Research. Improving the use of research evidence in guideline development: 1 (Guidelines for guidelines). Health Res Policy Syst. 2006;4:13
  6. Clinical Practice Guidelines: Evidence-Based Information and Recommendations for the Management of Localised Prostate Cancer. In: Canberra, Australia: Australian National Health and Medical Research Council; 2002;p. 137
  7. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care. 2003;12:18
  8. Cluzeau FA, Littlejohns P, Grimshaw JM, Feder G, Moran SE. Development and application of a generic methodology to assess the quality of clinical guidelines. Int J Qual Health Care. 1999;11:21
  9. Grilli R, Magrini N, Penna A, Mura G, Liberati A. Practice guidelines developed by specialty societies: the need for a critical appraisal. Lancet. 2000;355:103
  10. Middleton RG, Thompson IM, Austenfeld MS, Cooner WH, Correa RJ, Gibbons RP, et al. Prostate Cancer Clinical Guidelines Panel summary report on the management of clinically localized prostate cancer (The American Urological Association). J Urol. 1995;154:2144
  11. Thompson I, Thrasher JB, Aus G, Burnett AL, Canby-Hagino ED, Cookson MS, et al. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol. 2007;177:2106
  12. Guidelines on the Management of Prostate Cancer. London: British Association of Urological Surgeons; 2001;
  13. Heidenreich A, Aus G, Abbou CC, Bolla M, Joniau S, Matveev V, et al. Guidelines on Prostate Cancer. Arnhem, The Netherlands: European Association of Urology; 2007;
  14. Aus G, Abbou CC, Pacik D, Schmid HP, van Poppel H, Wolff J M, et al. EAU guidelines on prostate cancer. Eur Urol. 2001;40:97
  15. Guide to clinical preventive services: an effectiveness of 169 interventions: Appendix A. In: US Preventive Services Task Force Report. Edited by M Fisher. Baltimore: Williams & Wilkins 1989; p 388.
  16. Prostate Cancer: Clinical Practice Guidelines. In: Singapore: National Committee on Cancer Care; 2000;p. 42
  17. National Comprehensive Cancer Network: Prostate cancer early detection. NCCN Clinical Practice Guidelines in Oncology, v. 2.. 2007;www.nccn.org/professionals/physician_gls/PDF/prostate_detection.pdfAccessed July 1, 2007
  18. Guidance on Cancer Services: Improving Outcomes in Urological Cancers. In: London: National Institute for Clinical Excellence; 2002;p. 141
  19. Twaddle S. Clinical practice guidelines. Singapore Med J. 2005;46:681
  20. Lowe G, Twaddle S. The Scottish Intercollegiate Guidelines Network (SIGN): an update. Scott Med J. 2005;50:51
  21. Prostate Cancer Management: Clinical Guidelines. In: Dublin: Royal College of Surgeons in Ireland; 2002;p. 32
  22. Scales CD, Norris RD, Keitz SA, Peterson BL, Preminger GM, Vieweg J, et al. A critical assessment of the quality of reporting of randomized, controlled trials in the urology literature. J Urol. 2007;177:1090
  23. Scales CD, Norris RD, Peterson BL, Preminger GM, Dahm P. Clinical research and statistical methods in the urology literature. J Urol. 2005;174:1374
  24. Borawski KM, Norris RD, Fesperman SF, Vieweg J, Preminger GM, Dahm P. Levels of evidence in the urological literature. J Urol. 2007;178:1429
  25. Petrisor BA, Keating J, Schemitsch E. Grading the evidence: levels of evidence and grades of recommendation. Injury. 2006;37:321
  26. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet. 1998;352:609
  27. Moher D, Schulz KF, Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA. 2001;285:1987
  28. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement (Quality of Reporting of Meta-analyses). Lancet. 1999;354:1896
  29. Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B, et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians task force. Chest. 2006;129:174
  30. D'Amico AV, Whittington R, Malkowicz SB, Fondurulia J, Chen MH, Kaplan I, et al. Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer. J Clin Oncol. 1999;17:168
  31. Eddy D. A Manual for Assessing Health Practices and Designing Practice Policies: The Explicit Approach. In: Philadelphia: American College of Physicians; 1992;p. 126
  32. Agency for Health Care Policy and Research: Clinical Practice Guidelines Development, Methodological Perspectives. In: Washington D. C: US Department of Health and Human Services, Public Health Service; 1992;p. 115–127

 Editor's Note: This article is the second of 5 published in this issue for which category 1 CME credits can be earned. Instructions for obtaining credits are given with the questions on pages 790 and 791.

PII: S0022-5347(08)00933-6

doi: 10.1016/j.juro.2008.04.004

The Journal of Urology
Volume 180, Issue 2 , Pages 451-460 , August 2008

Article Tools

* Image Usage & Resolution